Grant: Alliance Grants
University of Victoria
$25,000.00
Recovery and reactivation of chiral precious metal catalysts applicable to pharmaceutical synthesis
FY 2024-25
Summary
Organic chemistry reactions are the foundation of discovering and manufacturing essential medicines and other high-value chemicals. Many of the most powerful and efficient approaches to connecting molecular fragments toward complex target compounds involve catalysts. These components of the reaction mixture enable control over new molecular connections, and are required for many transformations to occur. Among the most widely used catalysts in organic synthesis are those that contain palladium, a "platinum group" metal that is among Canada's Critical Minerals. Palladium is among the rarest elements on Earth, and is a finite resource. Its use as a catalyst in pharmaceutical and fine-chemical manufacture leads to increased costs and poorer sustainability of these essential processes. Catalysts are defined by their unchanging nature during the course of a chemical reaction, meaning they should be recoverable and reusable; however, decomposition of the palladium-containing molecules leads to expensive removal processes, meaning most of the palladium is simply disposed of in chemical waste.
We propose to design new palladium-based catalysts that can be recovered as intact, stable compounds directly from the chemical reaction mixture. These catalysts will enable a variety of chemical bond forming reactions relevant to pharmaceutical and fine-chemical synthesis. Then, once the chemical reaction is complete, the catalyst will convert into a 'dormant state', rendering it stable and easy to isolate as a discrete compound. Specific reactivation procedures will be developed to re-awaken these dormant catalysts for further reactions, enabling their constant re-use without the need for expensive waste remediation or metal reprocessing. Realizing this goal will significantly improve the economics and sustainability of our use of precious metal resources for chemical synthesis, leading ideally to a circular economy for these critical minerals.
Program
Alliance Grants
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
592372-2023
Name nom
Leitch, David DC
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3607
Research subject group en
Inorganic chemistry
Research subject group fr
Chimie inorganique
Research subject en
Catalysis
Research subject fr
Catalyse
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Recovery and reactivation of chiral precious metal catalysts applicable to pharmaceutical synthesis
Keywords
catalyst design; catalyst recycling; circular economy; critical minerals; homogeneous catalysis; organic synthesis; organometallic chemistry; platinum group metals; process chemistry; sustainability
Application summary
Organic chemistry reactions are the foundation of discovering and manufacturing essential medicines and other high-value chemicals. Many of the most powerful and efficient approaches to connecting molecular fragments toward complex target compounds involve catalysts. These components of the reaction mixture enable control over new molecular connections, and are required for many transformations to occur. Among the most widely used catalysts in organic synthesis are those that contain palladium, a "platinum group" metal that is among Canada's Critical Minerals. Palladium is among the rarest elements on Earth, and is a finite resource. Its use as a catalyst in pharmaceutical and fine-chemical manufacture leads to increased costs and poorer sustainability of these essential processes. Catalysts are defined by their unchanging nature during the course of a chemical reaction, meaning they should be recoverable and reusable; however, decomposition of the palladium-containing molecules leads to expensive removal processes, meaning most of the palladium is simply disposed of in chemical waste.
We propose to design new palladium-based catalysts that can be recovered as intact, stable compounds directly from the chemical reaction mixture. These catalysts will enable a variety of chemical bond forming reactions relevant to pharmaceutical and fine-chemical synthesis. Then, once the chemical reaction is complete, the catalyst will convert into a 'dormant state', rendering it stable and easy to isolate as a discrete compound. Specific reactivation procedures will be developed to re-awaken these dormant catalysts for further reactions, enabling their constant re-use without the need for expensive waste remediation or metal reprocessing. Realizing this goal will significantly improve the economics and sustainability of our use of precious metal resources for chemical synthesis, leading ideally to a circular economy for these critical minerals.